Baba TW, Koch J, Mittler ES, Greene M, Wyand M, Penninck D, Ruprecht R. Mucosal infection of neonatal rhesus monkeys with cell-free SIV. AIDS Res Hum Retrovirus 10:351-357, 1994.
Barbacci MB, Repke JT, Chaisson RE. Routine prenatal screening for HIV infection. Lancet 337:709-711, 1991.
Barton JJ, O'Connor TM, Cannon MJ, Weldon-Linne CM. Prevalence of human immunodeficiency virus in a general prenatal population. Am J Obstet Gynecol 160:1316-1324, 1989.
Bayer R. Public health policy and the AIDS epidemic. An end to HIV exceptionalism? N Engl J Med 324(21):1500-1504, 1991.
Bell LJ. Survey of prenatal care providers' screening practices. EPI Notes: Disease Prevention and Epidemiology Newsletter 19:1-2, 1997. South Carolina Department of Health and Environmental Control.
Biggar, RJ, Miotti PG, Taha TE, Mtimavalye L, Broadhead R, Justesen A, Yellin F, Liomba G, Miley W, Waters D, Chiphangwi JD, Goedert JJ. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 347:1647-1650, 1996.
Birkhead GS. New York AIDS Institute. Personal communication. 1998.
Birkhead GS, Warren BL, Charbonneau TT. Evidence of intermediate rates of perinatal HIV-1 transmission with partial 076 regimens: Results of observational study. Abstract presented at Fifth Conference on Retroviruses and Opportunistic Infections. Chicago, IL. February 1-5, 1998.
BlueSpruce J. Group Health Cooperative of Puget Sound. Personal communication, 1998.
Blum RW, Beuhring T, Wunderlich M, Resnick MD. Don't ask, they won't tell: The quality of adolescent health screening in five practice settings. Am J Publ Health 86:1768, 1996.
Borkowsky W, Krasinski K, Cao Y, Ho D, Pollack H, Moore T, Chen SH, Allen M, Tao PT. Correlation of perinatal transmission of human immunodeficiency virus type 1 with maternal viremia and lymphocyte phenotypes. J Pediatr 125:345-351, 1994.
Bremer JW, Lew JF, Cooper E, Hillyer GV, Pitt J, Handelsman E, Brambilla D, Moye J, Hoff R. Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study. J Pediatr 129:198-207, 1996.
Bulterys M, Chao A, Dushimimana A, Saah A. HIV-1 seroconversion after 20 months of age in a cohort of breast-fed children born to HIV-1 infected women in Rwanda. AIDS 9:93-94, 1995.
Bureau of Justice Statistics. Correctional Populations in the United States, 1995. 1997.
Byers Jr. RH, Caldwell MB, Davis S, Gwinn M, Lindegren ML. Projection of AIDS and HIV incidence among children born infected with HIV. Stat Med 17:169-181, 1998.
Cao Y, Krogstad P, Korber BT, Koup RA, Muldoon M, Macken C, Song JL, Jin Z, Zhao JQ, Clapp S, Chen IS, Ho DD, Ammann AJ. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med 3:549-552, 1997.
Carusi D, Learman LA, Posner SF. Human immunodeficiency virus test refusal in pregnancy: A challenge to voluntary testing. Obstet Gynecol 91(4):540-545, 1998.
Centers for Disease Control and Prevention (CDC). Public Health Service guidelines for antibody testing to prevent HIV infection and AIDS. MMWR 36:509-515, 1987.
CDC Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 43(RR-11), 1994.
CDC. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR 44(RR-4):1-10, 1995a.